Modified Child-Pugh grade vs albumin-bilirubin grade for predicting prognosis of hepatocellular carcinoma patients after hepatectomy

Table 2 Baseline characteristics of the 204 patients

Variable	All patients (n = 204)
Sex (male/female)	174/30
Age, yr	52.0 ± 11.4
BMI, kg/m2	23.2 ± 3.6
Cause of hepatitis (Hepatitis B/C/Others)	174/2/28
PH (yes/no)	48/156
Liver cirrhosis (yes/no)	120/84
P grade (A/B)	187/17
BCLC stage (0 or A/B/C)	113/62/29
PA, mg/L	198.5 (149.3-238.0)
ALB, g/L	41.0 ± 4.7
TBIL, μmol/L	13.3 (9.7-18.3)
PT, s	13.7 (13.0-14.5)
ALT, U/L	36.0 (26.3-56.0)
AFP, μg/L	76.4 (9.02-1082.5)
INR	1.0 (0.98-1.1)
PLT, × 109/L	135.0 (99.8-181.0)
Number of tumors (1/2/≥3)	161/27/16
Tumor size, cm	4.0 (3.0-6.5)
PVTT (yes/no)	30/174
Capsule formation (yes/no)	27/177
Differentiation (well/poor)	81/123
Surgical bleeding, mL	300 (180-575)
Blood transfusion (yes/no)	68/136
Type of liver resection (minor/major)	159/45
Intraoperative radiotherapy and/or chemotherapy (yes/no)	148/56
ALBI grade (1/2/3)	136/66/2
MCP grade (1/2/3)	110/52/42
Overall survival time, mo	44.0 (22.0-74.0)
Recurrence-free survival time, mo	22.0 (5.0-45.0)

BMI: Body mass index; PH: Portal hypertension; C-P: Child-Pugh; BCLC: Barcelona Clinic Liver Cancer; PVTT: Portal vein tumor thrombus; MCP: Modified Child-Pugh; ALBI: Albumin-bilirubin. Type of liver resection: Minor, ≤ 3 liver segments; major, ≥ 4 liver segments. Intraoperative radiotherapy: Implanted with radiation particles I¹²⁵ or I¹³¹. Intraoperative chemotherapy: Implanted with a chemotherapy pump.